Cell
Volume 74, Issue 6, 24 September 1993, Pages 957-967
Articlep53-dependent apoptosis modulates the cytotoxicity of anticancer agents
References (62)
- et al.
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
Biochem. Pharmacol.
(1990) - et al.
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours
Lancet
(1992) - et al.
Induction of apoptosis in fibroblasts by c-myc protein
Cell
(1992) - et al.
A genetic model for colorectal tumorigeneisis
Cell
(1990) - et al.
Timing and role of p53 gene mutation in the recurrence of glioma
Biochem. Biophys. Res. Commun.
(1991) - et al.
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Cell
(1992) - et al.
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Cell
(1992) - et al.
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Cell
(1992) - et al.
p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy
Blood
(1993) - et al.
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Cell
(1990)
Apoptosis
Biochemical events and relevance to cancer chemotherapy
FEBS Lett.
(1992)
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
Lancet
(1992)
Clinical pharmacology of cancer chemotherapy
Induction of E1A oncogene expression of cellular susceptibility to lysis by TNF
Nature
(1987)
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
Oncogene
(1990)
Function and regulation of the human multidrug resistance gene
Adv. Cancer Res.
(1993)
Thymocyte apoptosis induced by p53-dependent and independent pathways
Nature
(1993)
Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens
EMBO J.
(1992)
High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors
Oncogene
(1992)
Relation between p53 overexpression and established prognostic factors in breast cancer
Surgery
(1991)
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
Genes Dev.
(1993)
Drug-target interactions: only the first step in the commitment to a programmed cell death?
Br. J. Cancer
(1991)
Activation of programmed cell death by anticancer agents: cisplatin as a model system
Cancer Cells
(1990)
Cooperative interaction between c-myc and bcl-2 proto-oncogenes
Nature
(1992)
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia
J. Clin. Invest.
(1992)
Mammalian genes induced by radiation; activation of genes associated with growth control
Annu. Rev. Genet.
(1992)
Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
Oncogene
(1993)
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia
p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts
Genes Dev.
(1991)
No germline TP53 mutations detected in familial and bilateral testicular cancer
Genes Chromosom. Cancer
(1993)
Response to adversity: molecular control of gene activation following genotoxic stress
New Biol.
(1991)
Cited by (3027)
New mechanistic insights into halogen-dependent cytotoxic pattern of monohaloacetamide disinfection byproducts
2024, Journal of Hazardous MaterialsCoagulation factor V in breast cancer: a p53-regulated tumor suppressor and predictive marker for treatment response to chemotherapy
2024, Journal of Thrombosis and HaemostasisPreparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy
2023, International Journal of Biological MacromoleculesDevelopment of Benzimidazole a promising scaffold against Breast cancer via in silico approaches
2024, Journal of Integrated Science and TechnologyCaspase-2 protects against ferroptotic cell death
2024, Cell Death and Disease
Copyright © 1993